Ocaliva 5 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FJ59V
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,320
Award facts
- Contract value 100% obligated
- $10,320.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,320.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Localiva 5 mg tablets in 30-count packaging. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of September 11, 2025, carries no set-aside designation. The award represents a specific task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499.9 billion and valid through November 2026.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's SPE2DB contract enables the DLA to issue firm fixed-price delivery orders across a comprehensive portfolio of pharmaceutical products supporting military health system requirements. This delivery order for Localiva tablets continues the company's established pattern of fulfilling specialized pharmaceutical supply needs for federal healthcare operations, leveraging its capabilities as a certified woman-owned small business in the competitive federal pharmaceutical procurement market.
Quick answers
Who was awarded contract SPE2DB25FJ59V?
SPE2DB25FJ59V was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FJ59V worth?
The government has obligated $10,320 on SPE2DB25FJ59V.
Is contract SPE2DB25FJ59V an order under another contract?
Yes. SPE2DB25FJ59V is a delivery order under SPE2DB20D9136, an indefinite delivery contract.
Was contract SPE2DB25FJ59V competed?
The extent of competition for SPE2DB25FJ59V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award